Join Early Stage Investor Here And See How to Position Yourself for Matt McCall’s Next Potential 1,000% Winner. Download Your 5 Small Caps to Buy Now Report. It contains five promising stock picks Matt McCall personally selected. This report could be a huge asset for anyone looking to join the path towards financial freedom.
Table of Contents
5 Small Caps to Buy Now Report – What’s Inside?
Small innovative stocks not only were the top performers in the last three years…
They also took top spots in even bad market years like 2000 and 2008…
And they occupy most of the top spots in Matt McCall’s list of recommendations that saw huge gains, with extraordinary winners like:
- Ulta Beauty, which soared 2,043%… which could have turned every $5,000 invested into $107,150.
- Stamps.com, which rose 3,168%… which could have turned every $5,000 invested into $163,400.
- And Advanced Micro Devices, which grew 3,999%… which could have turned every $5,000 invested into $204,950.
Matt selected the most promising small-cap tech stocks for the special report: 5 Small Caps to Buy Now. This report could be a huge asset for anyone looking to join the path towards financial freedom.
It contains five promising stock picks Matt McCall personally selected after months of travel, research and intense study:
- The biotech that is investigating therapies for illnesses like leukemia and sickle cell, utilizing cutting-edge gene-editing processes to attack these diseases in novel ways.
- Matt’s favorite company in online casino gaming and sports betting. It not only has the #1 online gaming platform but also is beginning to make a dent in brick-and-mortar gaming, too.
- The company that may be the biggest winner of them all because it is backed by both Bill Gates and hedge fund billionaire David Shaw. This gem has built a platform that allows drug companies to speed up their drug discovery process, and all of the top 20 largest drug companies are already customers.
- Then there’s Matt McCall’s favorite play on both 5G and the Internet of Things. It’s a company with a slew of fascinating applications, like virtual reality tools for telemedicine, sensors for autonomous vehicles, augmented reality devices to help firefighters in smoky buildings, and much more.
- And, of course, you’ll receive all the details on BioXcel Therapeutics, the company that is pursuing an innovative solution for the problem of severe agitation.
Any one of these companies could deliver the 1,000% gains Matt McCall’s looking for… and which he have already found 23 times in the last 13 years!
That’s why Matt wants you to have his investment research and buy recommendations on all five small-cap stocks in 5 Small Caps to Buy Now…
Plus his insights on perhaps the most exciting new investment trend of 2020, special-purpose acquisition companies, in Three SPACs to Buy Now…
And Matt’s analysis on the One Nano-Cap Stock to Buy Now, a super-small company that has big plans to turn the error-filled world of medical billing and patient records upside down.
He wants you to have all this valuable research immediately, and that’s why he’s making it as easy as possible for you to join Early Stage Investor.
What’s included with Your Early Stage Investor Subscription?
- 5 Small Caps to Buy Now ($999 estimated value) This report reveals Matt’s five favorite stocks to become his next potential 1,000% winners. You’ll discover Matt McCall’s favorite small, high-growth companies in fast-growing industries like biotech, 5G, artificial intelligence, online gaming, the Internet of Things, and more.
- One Year of Early Stage Investor ($2,999 value) Matt will keep in touch with you every month with new stocks he’s recommending and why he finds them attractive. This includes updates and actionable advice on his current recommendations in the model portfolio and any relevant market commentary.
- Special Report: The One Nano Cap to Buy Now ($499 estimated value) You can purchase a single share of this company for less than $9 right now. But it’s quickly becoming a major player in cloud computing and the medical billing sector because it could help many companies eliminate their share of the $20 billion in medical billing errors. This special report will give you the name, ticker symbol, and my analysis of its tremendous future.
- Special Report: Three SPACs to Buy Now ($499 estimated value) You’ll discover three high-potential SPACs (special-purpose acquisition companies) with the same kind of potential as some of 2020’s top SPACs, like DraftKings (+294%), Immunovant (+134%), or Nikola (+264%).
- Special Report: Early Stage Investor Owner’s Manual ($299 estimated value) This short, easy-to-read manual explains the Early Stage Investor strategy: How Matt finds opportunities… the right way to buy and sell stocks… and many other key concepts on how to capitalize on the incredible potential of small tech companies. It is your blueprint for being successful in the world’s fastest-growing businesses. Reading this manual will get you up to speed on your process very quickly.
- Flash Alerts: When Matt issues a new buy or sell on a recommendation or simply when he needs to give you an urgent update — like his thoughts on unusual trading activity in one of his recommendations — he will be in touch.
- Early Access to New Special Reports: You’ll always be first to receive new research reports on the latest investment trends Matt uncovers.
Add it all up and you’re receiving over an estimated $5,000 worth of small-cap investment ideas, model portfolios and stock research…
Plus Matt McCall’s vigilant coverage of past recommendations and his up-to-the-minute analysis of new trends that are coming our way.
But you won’t pay even HALF of that amount today.
For about $5 per day, you can see which stocks he believes will be Matt’s next 1,000% winners and learn how to fast-track your journey to financial freedom by joining Early Stage Investor and claiming your huge discount.
Early Stage Investor Pricing
Most readers will pay $2,999 for one year of my elite high-growth investment research service.
But for a limited time, you can claim an entire year’s subscription for half that amount …
That’s just $1,499.
Early Stage Investor Refund Policy
You are fully backed by Matt McCall’s “100% Gainers” Guarantee.
If you don’t see at least one of the stocks featured in 5 Small Caps to Buy Now soar 100% or more over the next 12 months…
You’ll receive an additional year of Early Stage Investor for ZERO cost.
All you have to do is contact Matt’s Customer Care team at (800) 219-8592 or by emailing firstname.lastname@example.org to redeem it.
Just keep in mind: No Refund Policy in place.
Early Stage Investor is geared for investors who are looking to make massive gains from the best early-stage companies that will change the world.
Generally speaking, Matt McCall is holding these recommendations for 3 to 10 years, sometimes longer if his profits continue to soar.